Abbott Laboratories (NYSE:ABT) Issues FY 2025 Earnings Guidance
Abbott Laboratories (NYSE:ABT – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 5.050-5.250 for the period, compared to the consensus EPS estimate of 5.160. The company issued revenue guidance of -. Abbott Laboratories also updated its Q1 2025 guidance to 1.050-1.090 EPS. […]
More Stories
Original Games and Familiar Brands: Two Creative Routes in Online Casino Entertainment
A familiar film title can make a game recognisable before anyone opens it. An original character has a different task,...
Weather System Off North Carolina Could Become Nor’Easter or Tropical Storm: What to Know
By T.J. Muscaro The National Weather Service and its National Hurricane Center are tracking a storm system sitting off the...
Wall Street Review: Nasdaq Sinks 4.48 Percent as Inflation Fears Hit AI Stocks
By Panos Mourdoukoutas The Nasdaq Composite fell 4.48 percent for the week as hotter-than-expected inflation data sent Treasury yields higher...
Republican Attorney General Candidate New York, Saritha Komatireddy, Lays Out Her Vision
By Juliette Fairley Fresh off a fiery political debate last week, Republican challenger Saritha Komatireddy on Oct. 15 laid out...
Chaos and Violence Grip France as Far-Left Mobs Storm City Halls, Torch Streets
By Etienne Fauchaire PARIS—Stones and fireworks were already flying across Place de la République before Saturday’s demonstration against rising costs...
High Gas Prices Could Be the Key Issue That Swings the Senate
By Jeremy Lott Enough voters are fixated on the price of fuel that it could be the deciding issue in...